Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 3
1961 1
1962 3
1963 3
1964 2
1965 3
1966 6
1967 2
1968 1
1969 4
1970 8
1971 8
1972 2
1973 3
1974 5
1975 2
1976 4
1977 8
1978 9
1979 14
1980 12
1981 6
1982 12
1983 2
1984 8
1985 9
1986 11
1987 5
1988 8
1989 4
1990 1
1991 1
1992 3
1993 1
1994 5
1995 6
1996 3
1997 3
1998 9
1999 8
2000 4
2001 11
2002 4
2003 13
2004 18
2005 12
2006 9
2007 6
2008 10
2009 14
2010 12
2011 11
2012 23
2013 14
2014 23
2015 21
2016 24
2017 27
2018 32
2019 28
2020 25
2021 15
Text availability
Article attribute
Article type
Publication date

Search Results

520 results
Results by year
Filters applied: . Clear all
Page 1
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.
Zelniker TA, Wiviott SD, Raz I, Im K, Goodrich EL, Bonaca MP, Mosenzon O, Kato ET, Cahn A, Furtado RHM, Bhatt DL, Leiter LA, McGuire DK, Wilding JPH, Sabatine MS. Zelniker TA, et al. Among authors: kato et. Lancet. 2019 Jan 5;393(10166):31-39. doi: 10.1016/S0140-6736(18)32590-X. Epub 2018 Nov 10. Lancet. 2019. PMID: 30424892
Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus.
Kato ET, Silverman MG, Mosenzon O, Zelniker TA, Cahn A, Furtado RHM, Kuder J, Murphy SA, Bhatt DL, Leiter LA, McGuire DK, Wilding JPH, Bonaca MP, Ruff CT, Desai AS, Goto S, Johansson PA, Gause-Nilsson I, Johanson P, Langkilde AM, Raz I, Sabatine MS, Wiviott SD. Kato ET, et al. Circulation. 2019 May 28;139(22):2528-2536. doi: 10.1161/CIRCULATIONAHA.119.040130. Epub 2019 Mar 18. Circulation. 2019. PMID: 30882238 Clinical Trial.
Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus.
Zelniker TA, Wiviott SD, Raz I, Im K, Goodrich EL, Furtado RHM, Bonaca MP, Mosenzon O, Kato ET, Cahn A, Bhatt DL, Leiter LA, McGuire DK, Wilding JPH, Sabatine MS. Zelniker TA, et al. Among authors: kato et. Circulation. 2019 Apr 23;139(17):2022-2031. doi: 10.1161/CIRCULATIONAHA.118.038868. Circulation. 2019. PMID: 30786725
Screening for Thyroid Cancer.
Kato E, Niebuhr DW. Kato E, et al. Am Fam Physician. 2018 Mar 15;97(6):406-407. Am Fam Physician. 2018. PMID: 29671547 Free article. Review. No abstract available.
Validity of Short and Long Self-Administered Food Frequency Questionnaires in Ranking Dietary Intake in Middle-Aged and Elderly Japanese in the Japan Public Health Center-Based Prospective Study for the Next Generation (JPHC-NEXT) Protocol Area.
Yokoyama Y, Takachi R, Ishihara J, Ishii Y, Sasazuki S, Sawada N, Shinozawa Y, Tanaka J, Kato E, Kitamura K, Nakamura K, Tsugane S. Yokoyama Y, et al. Among authors: kato e. J Epidemiol. 2016 Aug 5;26(8):420-32. doi: 10.2188/jea.JE20150064. Epub 2016 Apr 9. J Epidemiol. 2016. PMID: 27064130 Free PMC article.
IgG4-related pleuritis with chylothorax.
Kato E, Takayanagi N, Ishiguro T, Kagiyama N, Shimizu Y, Sugita Y. Kato E, et al. Intern Med. 2014;53(14):1545-8. doi: 10.2169/internalmedicine.53.1642. Epub 2014 Jul 15. Intern Med. 2014. PMID: 25030570 Free article. Review.
520 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page